The Effectiveness of Endoscopic Gastroplasty for Obesity Treatment According to FDA Thresholds: Systematic Review and Meta-Analysis Based on Randomized Controlled Trials

被引：0
作者：
Antonio Coutinho Madruga-Neto
Wanderley Marques Bernardo
Diogo Turiani Hourneaux de Moura
Vitor Ottoboni Brunaldi
Rafael Krieger Martins
Iatagan Rocha Josino
Eduardo Turiani Hourneaux de Moura
Thiago Ferreira de Souza
Marco Aurélio Santo
Eduardo Guimarães Hourneaux de Moura
机构：
[1] University of São Paulo Medical School,Gastrointestinal Endoscopy Unit, Hospital das Clínicas
[2] University of São Paulo Medical School,Bariatric and Metabolic Surgery Unit, Hospital das Clínicas
来源：
Obesity Surgery | 2018年 / 28卷
关键词：
Obesity; Gastroplasty; Endoscopy; Endoluminal therapy; Endoscopic therapy; Endoscopic suture; Systematic review; Meta-analysis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Endoscopic bariatric therapies (EBTs) are promising alternatives to conventional surgery for obesity. The aim of this study is to compare efficacy and safety through a systematic review and meta-analysis of the endoscopic gastroplasty techniques versus conservative treatment. We searched MEDLINE, EMBASE, Cochrane CENTRAL, Lilacs/Bireme. Randomized controlled trials (RCTs) enrolling obese patients comparing endoscopic gastroplasty to sham or diet/exercise were considered eligible. Among 6014 records, three RCTs were selected for meta-analysis. The total sample was 459 patients (312 EBTs vs 147 control). Mean total body weight loss in the intervention group (IG) was 4.8% higher than the control group (CG) at 12 months (p = 0.01). The IG responder rate was 44.31% at 12 months. Therefore, the endoscopic gastroplasty is more effective than conservative therapies but do not achieve FDA thresholds.
引用
收藏
页码：2932 / 2940
页数：8
相关论文
共 214 条
[11]  
Lachin JM(2017)Laparoscopic sleeve gastrectomy then and now: an updated systematic review of the progress and short-term outcomes over the last 5 years Surg Laparosc Endosc Percutan Tech 27 307-317
[12]  
Walker EA(2004)Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery N Engl J Med 351 2683-2693
[13]  
Nathan DM(2017)Clinical practice update: expert review on endoscopic bariatric therapies Gastroenterology 152 716-729
[14]  
Schauer PR(2017)Endoscopic sleeve gastroplasty for obesity: a multicenter study of 248 patients with 24 months follow-up Obes Surg 27 2649-2655
[15]  
Bhatt DL(2017)Randomized sham-controlled trial evaluating efficacy and safety of endoscopic gastric plication for primary obesity: the ESSENTIAL trial Obesity (Silver Spring) 25 294-301
[16]  
Kirwan JP(2017)MILEPOST multicenter randomized controlled trial: 12-month weight loss and satiety outcomes after pose (SM) vs. medical therapy Obes Surg 27 310-322
[17]  
Wolski K(2013)Benefit-risk paradigm for clinical trial design of obesity devices: FDA proposal Surg Endosc 27 702-707
[18]  
Brethauer SA(2017)Endoscopic bariatric and metabolic therapies: surgical analogues and mechanisms of action Clin Gastroenterol Hepatol 15 619-630
[19]  
Navaneethan SD(2017)Endoscopic bariatric and metabolic therapies: new and emerging technologies Gastroenterology 152 1791-1801
[20]  
Aminian A(2009)Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement PLoS Med 6 e1000097-12
12345678910